2,327 research outputs found
Design of sensor electronics for electrical capacitance tomography
The design of the sensor electronics for a tomographic imaging system based on electrical capacitance sensors is described. The performance of the sensor electronics is crucial to the performance of the imaging system. The problems associated with such a measurement process are discussed and solutions to these are described. Test results show that the present design has a resolution of 0.3 femtofarad. (For a 12-electrode system imaging an oil/gas flow, this represents a 2% gas void fraction change at the centre of the pipe) with a low noise level of 0.08 fF (RMS value), a large dynamic range of 76 dB and a data acquisition speed of 6600 measurements per second. This enables sensors with up to 12 electrodes to be used in a system with a maximum imaging rate of 100 frames per second, and thus provides an improved image resolution over the earlier 8-electrode system and an adequate electrode area to give sufficient measurement sensitivit
Advances in the identification and analysis of allele-specific expression
Allele-specific expression (ASE) is essential for normal development and many cellular processes
but, if impaired, can result in disease. ASE is a feature of organisms with genomes consisting of
more than one set of homologous chromosomes. The higher the number of chromosome sets
(ploidy) per cell, the higher the potential complexity of ASE. Humans, for instance, are diploid
(except germ cells, which are haploid), resulting in multiple possible expression states in time and
space for each set of alleles. ASE is invoked and modulated by both genetic and epigenetic
changes, affecting the underlying DNA sequence or chromatin of each allele, respectively.
Although numerous methods have been developed to assay ASE, they usually require RNA to be
available and are dependent upon genetic polymorphisms (such as single nucleotide polymorphisms (SNPs)) to differentiate between allelic transcripts. The rapid convergence to secondgeneration sequencing as the method of choice to examine genomic, epigenomic and
transcriptomic data enables an integrated and more general approach to define and predict ASE,
independent of SNPs. This ‘Omni-Seq’ approach has the potential to advance our understanding
of the biology and pathophysiology of ASE-mediated processes by elucidating subtle combinatorial effects, leading to the accurate delineation of sub-phenotypes with consequential benefit for
improved insight into disease etiology
Recommended from our members
Electrical capacitance tomography for flow imaging: System model for development of image reconstruction algorithms and design of primary sensors
A software tool that facilitates the development of image reconstruction algorithms, and the design of optimal capacitance sensors for a capacitance-based 12-electrode tomographic flow imaging system are described. The core of this software tool is the finite element (FE) model of the sensor, which is implemented in OCCAM-2 language and run on the Inmos T800 transputers. Using the system model, the in-depth study of the capacitance sensing fields and the generation of flow model data are made possible, which assists, in a systematic approach, the design of an improved image-reconstruction algorithm. This algorithm is implemented on a network of transputers to achieve a real-time performance. It is found that the selection of the geometric parameters of a 12-electrode sensor has significant effects on the sensitivity distributions of the capacitance fields and on the linearity of the capacitance data. As a consequence, the fidelity of the reconstructed images are affected. Optimal sensor designs can, therefore, be provided, by accommodating these effect
Human-specific CpG 'beacons' identify human-specific prefrontal cortex H3K4me3 chromatin peaks.
Background: Targeted recruitment of chromatin-modifying enzymes to clusters of CpG dinucleotides contributes toward the formation of accessible chromatin. By interprimate comparison we previously identified the set of nonpolymorphic human-specific CpGs (CpG 'beacons') and revealed that these loci were enriched for human disease traits. Due to their human-specific CpG density change, extreme CpG 'beacon' clusters (≥20 CpG beacons/kb) were predicted to identify permissive chromatin peaks within the human genome. Aim: We set out to explore these sequence-defined regions for evidence of an active chromatin signature. Results: Using available comparative primate epigenomic data from neurons of the prefrontal cortex, we show that these CpG 'beacon' clusters are indeed enriched for being human-specific H3K4me3 peaks (χ(2): p < 2.2 × 10(-16)) and thus predictive of permissive chromatin states. These sequence regions had a higher predictive value than previous selective analyses. We also show that both human-specific H3K4me3 and CpG 'beacon' clusters are increased within current and ancestral telomeric regions, supporting an association with recombination, which is higher towards the distal ends of chromosomes. Conclusion: Therefore, CpG-focused comparative sequence analysis can precisely pinpoint chromatin structures that contribute to the human-specific phenotype and further supports an integrated approach in genomic and epigenomic studies
T cell clones specific for hybrid I-A molecules. Discrimination with monoclonal anti-I-A (k) antibodies
Alloreactive and soluble antigen-reactive, I-A-restricted T cell clones were examined for their ability to recognize hybrid I-A antigens. Several clones that recognized hybrid I-A(b)/I-A(k) molecules on (C57BL/6 x A/J)F(1) [(B6A)F(1)] spleen cells were studied. We were able to distinguish clones that recognized hybrid I-A molecules of the A(b)(a)A(k)(β) type from those that recognized A(k)(a)A(b)(β) molecules. We reached this conclusion by considering data from three independent types of experiments. (a) Monoclonal antibodies were used to inhibit T cell stimulation. Antibodies 10.2.16 and H116.32 distinguished two mutually exclusive “families” of T cell clones. One group of clones was inhibited by 10-2.16 and not H116.32, the other group exhibited reciprocal inhibition. (b) T cell proliferation was assayed using antigen-presenting cells from B6.C-H-2(bml2) (bml2) and [bml2 × B10.A(4R)]F(1) mice. Because the bml2 strain has a mutation that results in an altered A(b)(β) polypeptide chain (A(bm12)(β)), we reasoned that clones that could recognize the [bm12 × B 10.A(4R)]F(1) cells were recognizing A(b)(a)A(k)(β) molecules. Alternatively, clones not recognizing [bml2 × B10.A(4R)]F(1) cells had specificity for A(k)(a)A(b)(β) molecules. (c) I-A molecules immunoprecipitated from radiolabeled (B6A)F(1) splenocyte extracts were analyzed by two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. These experiments confirmed an earlier report that antibody 10.2.16 recognized determinants on the A(k)(β) chain (12). Antibody H116.32 immunoprecipitated products consistent with recognition of A(k)(a) determinants. Taken together, these three types of results offer conclusive evidence that T cell clones recognizing “hybrid” I-A molecules use either A(b(k)A(k)(β) or A(k)(a)A(b)(β) molecules as recognition or restriction sites. Clones whose proliferation was supported by [bm 12 x B10.A(4R)]F(1) cells and blocked by anti-I-A(k) antibody 10-2.16 recognized A(b)(a)A(k)(β) B molecules. Clones that were blocked by antibody H116.32 and did not recognize [bml2 X B10.A(4R)]F(1) cells use a recognition site(s) on A(b)(a)A(k)(β) molecules. Thus, we can demonstrate both functionally and biochemically that hybrid F(1) I-A molecules of the structure A(k)(a)A(b)(β) and A(b)(a)A(k)(β) both exist on (B6A)F(1) splenocytes and that both configurations are used in immune recognition phenomena
Testing the cognitive-behavioural maintenance models across DSM-5 bulimic-type eating disorder diagnostic groups: A multi-centre study
The original cognitive-behavioural (CB) model of bulimia nervosa, which provided the basis for the widely used CB therapy, proposed that specific dysfunctional cognitions and behaviours maintain the disorder. However, amongst treatment completers, only 40–50 % have a full and lasting response. The enhanced CB model (CB-E), upon which the enhanced version of the CB treatment was based, extended the original approach by including four additional maintenance factors. This study evaluated and compared both CB models in a large clinical treatment seeking sample (N = 679), applying both DSM-IV and DSM-5 criteria for bulimic-type eating disorders. Application of the DSM-5 criteria reduced the number of cases of DSM-IV bulimic-type eating disorders not otherwise specified to 29.6 %. Structural equation modelling analysis indicated that (a) although both models provided a good fit to the data, the CB-E model accounted for a greater proportion of variance in eating-disordered behaviours than the original one, (b) interpersonal problems, clinical perfectionism and low self-esteem were indirectly associated with dietary restraint through over-evaluation of shape and weight, (c) interpersonal problems and mood intolerance were directly linked to binge eating, whereas restraint only indirectly affected binge eating through mood intolerance, suggesting that factors other than restraint may play a more critical role in the maintenance of binge eating. In terms of strength of the associations, differences across DSM-5 bulimic-type eating disorder diagnostic groups were not observed. The results are discussed with reference to theory and research, including neurobiological findings and recent hypotheses
An extragalactic supernebula confined by gravity
Little is known about the origins of the giant star clusters known as
globular clusters. How can hundreds of thousands of stars form simultaneously
in a volume only a few light years across the distance of the sun to its
nearest neighbor? Radiation pressure and winds from luminous young stars should
disperse the star-forming gas and disrupt the formation of the cluster.
Globular clusters in our Galaxy cannot provide answers; they are billions of
years old. Here we report the measurement of infrared hydrogen recombination
lines from a young, forming super star cluster in the dwarf galaxy, NGC 5253.
The lines arise in gas heated by a cluster of an estimated million stars, so
young that it is still enshrouded in gas and dust, hidden from optical view. We
verify that the cluster contains 4000-6000 massive, hot "O" stars. Our
discovery that the gases within the cluster are bound by gravity may explain
why these windy and luminous O stars have not yet blown away the gases to allow
the cluster to emerge from its birth cocoon. Young clusters in "starbursting"
galaxies in the local and distant universe may be similarly gravitationally
confined and cloaked from view.Comment: Letter to Natur
Human-specific CpG "beacons" identify loci associated with human-specific traits and disease.
Regulatory change has long been hypothesized to drive the delineation of the human phenotype from other closely related primates. Here we provide evidence that CpG dinucleotides play a special role in this process. CpGs enable epigenome variability via DNA methylation, and this epigenetic mark functions as a regulatory mechanism. Therefore, species-specific CpGs may influence species-specific regulation. We report non-polymorphic species-specific CpG dinucleotides (termed "CpG beacons") as a distinct genomic feature associated with CpG island (CGI) evolution, human traits and disease. Using an inter-primate comparison, we identified 21 extreme CpG beacon clusters (≥ 20/kb peaks, empirical p < 1.0 × 10(-3)) in humans, which include associations with four monogenic developmental and neurological disease related genes (Benjamini-Hochberg corrected p = 6.03 × 10(-3)). We also demonstrate that beacon-mediated CpG density gain in CGIs correlates with reduced methylation in these species in orthologous CGIs over time, via human, chimpanzee and macaque MeDIP-seq. Therefore mapping into both the genomic and epigenomic space the identified CpG beacon clusters define points of intersection where a substantial two-way interaction between genetic sequence and epigenetic state has occurred. Taken together, our data support a model for CpG beacons to contribute to CGI evolution from genesis to tissue-specific to constitutively active CGIs
DNA Methylome Alterations are Associated with Airway Macrophage Differentiation and Phenotype During Lung Fibrosis
RATIONALE: Airway macrophages (AMs) are key regulators of the lung environment and are implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF), a fatal respiratory disease with no cure. However, knowledge of epigenetics of AMs in IPF are limited. METHODS: We undertook DNA methylation profiling using Illumina EPIC (850k) arrays in sorted AMs from Healthy (n=14) and IPF (n=30) donors. Cell-type deconvolution was performed using reference myeloid-cell DNA methylomes. MEASUREMENTS AND MAIN RESULTS: Our analysis revealed epigenetic heterogeneity was a key characteristic of IPF-AMs. DNAm 'clock' analysis indicated epigenetic alterations in IPF-AMs was not associated with accelerated ageing. In differential DNAm analysis, we identified numerous differentially methylated positions (DMPs, n=11) and regions (DMRs, n=49) between healthy and IPF AMs respectively. DMPs and DMRs encompassed genes involved in lipid (LPCAT1) and glucose (PFKFB3) metabolism and importantly, DNAm status was associated with disease severity in IPF. CONCLUSIONS: Collectively, our data identify that changes in the epigenome are associated with development and function of AMs in the IPF lung
Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study.
OBJECTIVE: To examine the timing and duration of RSV bronchiolitis hospital admission among term and preterm infants in England and to identify risk factors for bronchiolitis admission.
DESIGN: A population-based birth cohort with follow-up to age 1 year, using the Hospital Episode Statistics database. SETTING: 71 hospitals across England.
PARTICIPANTS: We identified 296618 individual birth records from 2007/08 and linked to subsequent hospital admission records during the first year of life.
RESULTS: In our cohort there were 7189 hospital admissions with a diagnosis of bronchiolitis, 24.2 admissions per 1000 infants under 1 year (95%CI 23.7-24.8), of which 15% (1050/7189) were born preterm (47.3 bronchiolitis admissions per 1000 preterm infants (95% CI 44.4-50.2)). The peak age group for bronchiolitis admissions was infants aged 1 month and the median was age 120 days (IQR = 61-209 days). The median length of stay was 1 day (IQR = 0-3). The relative risk (RR) of a bronchiolitis admission was higher among infants with known risk factors for severe RSV infection, including those born preterm (RR = 1.9, 95% CI 1.8-2.0) compared with infants born at term. Other conditions also significantly increased risk of bronchiolitis admission, including Down's syndrome (RR = 2.5, 95% CI 1.7-3.7) and cerebral palsy (RR = 2.4, 95% CI 1.5-4.0).
CONCLUSIONS: Most (85%) of the infants who are admitted to hospital with bronchiolitis in England are born at term, with no known predisposing risk factors for severe RSV infection, although risk of admission is higher in known risk groups. The early age of bronchiolitis admissions has important implications for the potential impact and timing of future active and passive immunisations. More research is needed to explain why babies born with Down's syndrome and cerebral palsy are also at higher risk of hospital admission with RSV bronchiolitis
- …